<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35514142</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-3503</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Transactions of the Royal Society of Tropical Medicine and Hygiene</Title><ISOAbbreviation>Trans R Soc Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil.</ArticleTitle><Pagination><StartPage>1007</StartPage><EndPage>1014</EndPage><MedlinePgn>1007-1014</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/trstmh/trac030</ELocationID><Abstract><AbstractText Label="BACKGROUND">A growing number of long COVID cases after infection have been reported. By definition, long COVID is the condition whereby affected individuals do not recover for several weeks or months following the onset of symptoms suggestive of COVID-19, the profile and timeline of which remains uncertain.</AbstractText><AbstractText Label="METHODS">In this work, in-home, outpatient and hospitalized COVID-19 positive patients were monitored for up to 14 mo to establish the prevalence of long COVID symptoms and their correlation with age, pre-existing comorbidities and course of acute infection. The longitudinal study included 646 positive patients who were monitored once a month.</AbstractText><AbstractText Label="RESULTS">From the whole population, 50.2% presented with long COVID syndrome. Twenty-three different symptoms were reported. Most frequent were fatigue (35.6%), persistent cough (34.0%), dyspnea (26.5%), loss of smell/taste (20.1%) and frequent headaches (17.3%). Mental disorders (20.7%), change in blood pressure (7.4%) and thrombosis (6.2%) were also reported. Most patients presented with 2-3 symptoms at the same time. Long COVID started after mild, moderate and severe infection in 60, 13 and 27% of cases, respectively, and it was not restricted to specific age groups.</AbstractText><AbstractText Label="CONCLUSIONS">Older patients tended to have more severe symptoms, leading to a longer post-COVID-19 period. The presence of seven comorbidities was correlated with the severity of infection, and severity itself was the main factor that determined the duration of symptoms in long COVID cases.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Miranda</LastName><ForeName>Daniel A P</ForeName><Initials>DAP</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Sarah V C</ForeName><Initials>SVC</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filgueiras</LastName><ForeName>Priscilla S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biological Sciences, Federal University of Minas Gerais, 6627 Presidente Ant&#xf4;nio Carlos Avenue, Belo Horizonte, Minas Gerais 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corsini</LastName><ForeName>Camila A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Nathalie B F</ForeName><Initials>NBF</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, 501 D. W. Brooks Drive, Athens, Georgia 30602-7387, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Raphael A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Hospital da Baleia, Benjamin Guimar&#xe3;es Foundation. 1464 Juramento Street, Belo Horizonte, Minas Gerais 30285-408, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Maria Izabella V A R C</ForeName><Initials>MIVARC</Initials><AffiliationInfo><Affiliation>Hospital Metropolitano Dr Celio de Castro, 311 Dona Luiza Street, Belo Horizonte, Minas Gerais 30620-090, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilela</LastName><ForeName>Raquel V R</ForeName><Initials>RVR</Initials><AffiliationInfo><Affiliation>Hospital da Baleia, Benjamin Guimar&#xe3;es Foundation. 1464 Juramento Street, Belo Horizonte, Minas Gerais 30285-408, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Gabriel R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Biosyst ems Informatics, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grenfell</LastName><ForeName>Rafaella F Q</ForeName><Initials>RFQ</Initials><AffiliationInfo><Affiliation>Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais 30190-002, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biological Sciences, Federal University of Minas Gerais, 6627 Presidente Ant&#xf4;nio Carlos Avenue, Belo Horizonte, Minas Gerais 31270-901, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, 501 D. W. Brooks Drive, Athens, Georgia 30602-7387, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trans R Soc Trop Med Hyg</MedlineTA><NlmUniqueID>7506129</NlmUniqueID><ISSNLinking>0035-9203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postinfection</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35514142</ArticleId><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pii">6581500</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>